Hims & Hers (HIMS) is down -19.1%, or -$12.65 to $53.76.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Unusually active option classes on open February 21st
- Novo Nordisk up 6%, Hims & Hers down 15% as FDA says Ozempic shortage over
- Hims & Hers acquires U.S.-based peptide facility in California
- Hims & Hers Health (HIMS) Upward Trajectory Boosted by Recent Acquisition
- Super Micro Computer’s (SMCI) Rally Costs Short Sellers Billions of Dollars